Cite

HARVARD Citation

    Zhang, L. et al. (2020). Safety and efficacy of eltrombopag plus pulsed dexamethasone as first‐line therapy for immune thrombocytopenia. British journal of haematology. pp. 369-378. [Online]. 
  
Back to record